アミノ酸代謝の病気世界市場の発展状況と動向 2024-2030
英文タイトル: Global Amino Acid Metabolism Disease Market Insights, Forecast to 2030
販売価格(消費税別)
個人版
マルチユーザー版
企業版
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
価格表記: USDを日本円(税抜)に換算,本日の銀行送金レート: 1USD=161円。
※米ドル表示価格+10%消費税。
※ご注文方法:お問い合わせフォームまたはメールにてご連絡ください。
支払方法:「銀行振込」の場合, 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期:原則として、受注後2~4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8~10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。
概要
本報告書はアミノ酸代謝の病気市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはアミノ酸代謝の病気の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。
世界のアミノ酸代謝の病気市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはアミノ酸代謝の病気のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にアミノ酸代謝の病気市場を分類しています。本研究に含まれる主な企業は:Merck、Novartis、Takeda Pharmaceutical、Astra Zeneca、Boehringer Ingelheim、KOWA、Kythera、Fuji yakuhin、LG Life Science、Metsubishi Tanabe Pharma
地域別市場区分、地域別分析は以下の通り:
アメリカとカナダ
中国
アジア
ヨーロッパ
中東、アフリカ、ラテンアメリカ
タイプ別市場セグメント:
OTC
Rx Drugs
用途別の市場セグメント:
Hospital
Retail Pharmacy
本レポートの詳細内容
世界のアミノ酸代謝の病気市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、アミノ酸代謝の病気タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のアミノ酸代謝の病気収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のアミノ酸代謝の病気市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、アミノ酸代謝の病気市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。
アミノ酸代謝の病気のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。
章の概要
第1章:アミノ酸代謝の病気のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント(製品タイプ、用途など)のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。(2019~2030)
第2章:アミノ酸代謝の病気の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。(2019~2030)
第3章アミノ酸代謝の病気企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。(2019~2030)
第4章:各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。(2019~2024)
第5章:アミノ酸代謝の病気の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。(2019~2030)
第6章:北米(米国、カナダ)のタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第7章:ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第8章:中国の種類別、および用途別、各セグメントの収益。(2019~2030)
第9章アジア(中国を除く)の種類別、用途別、地域別、セグメントごとの収益。(2019~2030)
第10章:中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。(2019~2030)
第11章:アミノ酸代謝の病気の主要企業の概要を提供し、製品の説明と仕様、アミノ酸代謝の病気の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。(2019~2024)
第12章:アナリストの見解/結論
概要
Amino Acid Metabolism Drug is used to treat the gout and Hyperuricemia. Market Analysis and Insights: Global Amino Acid Metabolism Disease Market The global Amino Acid Metabolism Disease market is projected to grow from US$ 2857 million in 2024 to US$ 4007 million by 2030, at a Compound Annual Growth Rate (CAGR) of 5.8% during the forecast period. The Metabolic Disorders Drugs market refers to the pharmaceuticals and medications used for the treatment of disorders related to metabolism, such as diabetes, obesity, hyperlipidemia, and thyroid disorders. This market encompasses various therapeutic areas including antidiabetic drugs, lipid-lowering agents, and thyroid hormone replacements. The Metabolic Disorders Drugs market has been experiencing significant growth due to factors such as the increasing prevalence of metabolic disorders globally, sedentary lifestyles, and unhealthy dietary habits. Key players in the market include pharmaceutical companies, biotechnology firms, and generic drug manufacturers. Geographically, North America currently holds a significant market share, followed by Europe. However, the market in Asia Pacific is expected to witness substantial growth in the coming years, driven by the rising incidence of metabolic disorders and improving healthcare infrastructure. Report Covers: This report presents an overview of global market for Amino Acid Metabolism Disease market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. This report researches the key producers of Amino Acid Metabolism Disease, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Amino Acid Metabolism Disease, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries. This report focuses on the Amino Acid Metabolism Disease revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Amino Acid Metabolism Disease market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way. This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Amino Acid Metabolism Disease revenue, projected growth trends, production technology, application and end-user industry. Descriptive company profiles of the major global players, including Merck, Novartis, Takeda Pharmaceutical, Astra Zeneca, Boehringer Ingelheim, KOWA, Kythera, Fuji yakuhin and LG Life Science, etc. Market Segmentation By Company Merck Novartis Takeda Pharmaceutical Astra Zeneca Boehringer Ingelheim KOWA Kythera Fuji yakuhin LG Life Science Metsubishi Tanabe Pharma Segment by Type OTC Rx Drugs Segment by Application Hospital Retail Pharmacy By Region North America United States Canada Europe Germany France UK Italy Russia Nordic Countries Rest of Europe China Asia (excluding China) Japan South Korea China Taiwan Southeast Asia India Latin America, Middle East & Africa Brazil Mexico Turkey Israel GCC Countries Chapter Outline Chapter Outline Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term. Chapter 2: Revenue of Amino Acid Metabolism Disease in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry. Chapter 3: Detailed analysis of Amino Acid Metabolism Disease companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc. Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments. Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets. Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment. Chapter 7: Europe by Type, by Application and by country, revenue for each segment. Chapter 8: China by Type, and by Application, revenue for each segment. Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment. Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment. Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Amino Acid Metabolism Disease revenue, gross margin, and recent development, etc. Chapter 12: Analyst's Viewpoints/Conclusions
総目録
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Amino Acid Metabolism Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 OTC
1.2.3 Rx Drugs
1.3 Market by Application
1.3.1 Global Amino Acid Metabolism Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Retail Pharmacy
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Amino Acid Metabolism Disease Market Perspective (2019-2030)
2.2 Global Amino Acid Metabolism Disease Growth Trends by Region
2.2.1 Amino Acid Metabolism Disease Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Amino Acid Metabolism Disease Historic Market Size by Region (2019-2024)
2.2.3 Amino Acid Metabolism Disease Forecasted Market Size by Region (2025-2030)
2.3 Amino Acid Metabolism Disease Market Dynamics
2.3.1 Amino Acid Metabolism Disease Industry Trends
2.3.2 Amino Acid Metabolism Disease Market Drivers
2.3.3 Amino Acid Metabolism Disease Market Challenges
2.3.4 Amino Acid Metabolism Disease Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Amino Acid Metabolism Disease by Players
3.1.1 Global Amino Acid Metabolism Disease Revenue by Players (2019-2024)
3.1.2 Global Amino Acid Metabolism Disease Revenue Market Share by Players (2019-2024)
3.2 Global Amino Acid Metabolism Disease Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Amino Acid Metabolism Disease, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Amino Acid Metabolism Disease Market Concentration Ratio
3.4.1 Global Amino Acid Metabolism Disease Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Amino Acid Metabolism Disease Revenue in 2023
3.5 Global Key Players of Amino Acid Metabolism Disease Head office and Area Served
3.6 Global Key Players of Amino Acid Metabolism Disease, Product and Application
3.7 Global Key Players of Amino Acid Metabolism Disease, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Amino Acid Metabolism Disease Breakdown Data by Type
4.1 Global Amino Acid Metabolism Disease Historic Market Size by Type (2019-2024)
4.2 Global Amino Acid Metabolism Disease Forecasted Market Size by Type (2025-2030)
5 Amino Acid Metabolism Disease Breakdown Data by Application
5.1 Global Amino Acid Metabolism Disease Historic Market Size by Application (2019-2024)
5.2 Global Amino Acid Metabolism Disease Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Amino Acid Metabolism Disease Market Size (2019-2030)
6.2 North America Amino Acid Metabolism Disease Market Size by Type
6.2.1 North America Amino Acid Metabolism Disease Market Size by Type (2019-2024)
6.2.2 North America Amino Acid Metabolism Disease Market Size by Type (2025-2030)
6.2.3 North America Amino Acid Metabolism Disease Market Share by Type (2019-2030)
6.3 North America Amino Acid Metabolism Disease Market Size by Application
6.3.1 North America Amino Acid Metabolism Disease Market Size by Application (2019-2024)
6.3.2 North America Amino Acid Metabolism Disease Market Size by Application (2025-2030)
6.3.3 North America Amino Acid Metabolism Disease Market Share by Application (2019-2030)
6.4 North America Amino Acid Metabolism Disease Market Size by Country
6.4.1 North America Amino Acid Metabolism Disease Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Amino Acid Metabolism Disease Market Size by Country (2019-2024)
6.4.3 North America Amino Acid Metabolism Disease Market Size by Country (2025-2030)
6.4.4 the United States
6.4.5 Canada
7 Europe
7.1 Europe Amino Acid Metabolism Disease Market Size (2019-2030)
7.2 Europe Amino Acid Metabolism Disease Market Size by Type
7.2.1 Europe Amino Acid Metabolism Disease Market Size by Type (2019-2024)
7.2.2 Europe Amino Acid Metabolism Disease Market Size by Type (2025-2030)
7.2.3 Europe Amino Acid Metabolism Disease Market Share by Type (2019-2030)
7.3 Europe Amino Acid Metabolism Disease Market Size by Application
7.3.1 Europe Amino Acid Metabolism Disease Market Size by Application (2019-2024)
7.3.2 Europe Amino Acid Metabolism Disease Market Size by Application (2025-2030)
7.3.3 Europe Amino Acid Metabolism Disease Market Share by Application (2019-2030)
7.4 Europe Amino Acid Metabolism Disease Market Size by Country
7.4.1 Europe Amino Acid Metabolism Disease Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Amino Acid Metabolism Disease Market Size by Country (2019-2024)
7.4.3 Europe Amino Acid Metabolism Disease Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Amino Acid Metabolism Disease Market Size (2019-2030)
8.2 China Amino Acid Metabolism Disease Market Size by Type
8.2.1 China Amino Acid Metabolism Disease Market Size by Type (2019-2024)
8.2.2 China Amino Acid Metabolism Disease Market Size by Type (2025-2030)
8.2.3 China Amino Acid Metabolism Disease Market Share by Type (2019-2030)
8.3 China Amino Acid Metabolism Disease Market Size by Application
8.3.1 China Amino Acid Metabolism Disease Market Size by Application (2019-2024)
8.3.2 China Amino Acid Metabolism Disease Market Size by Application (2025-2030)
8.3.3 China Amino Acid Metabolism Disease Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Amino Acid Metabolism Disease Market Size (2019-2030)
9.2 Asia Amino Acid Metabolism Disease Market Size by Type
9.2.1 Asia Amino Acid Metabolism Disease Market Size by Type (2019-2024)
9.2.2 Asia Amino Acid Metabolism Disease Market Size by Type (2025-2030)
9.2.3 Asia Amino Acid Metabolism Disease Market Share by Type (2019-2030)
9.3 Asia Amino Acid Metabolism Disease Market Size by Application
9.3.1 Asia Amino Acid Metabolism Disease Market Size by Application (2019-2024)
9.3.2 Asia Amino Acid Metabolism Disease Market Size by Application (2025-2030)
9.3.3 Asia Amino Acid Metabolism Disease Market Share by Application (2019-2030)
9.4 Asia Amino Acid Metabolism Disease Market Size by Region
9.4.1 Asia Amino Acid Metabolism Disease Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Amino Acid Metabolism Disease Market Size by Region (2019-2024)
9.4.3 Asia Amino Acid Metabolism Disease Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Type
10.2.1 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Application
10.3.1 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country
10.4.1 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Amino Acid Metabolism Disease Introduction
11.1.4 Merck Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.1.5 Merck Recent Developments
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Amino Acid Metabolism Disease Introduction
11.2.4 Novartis Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.2.5 Novartis Recent Developments
11.3 Takeda Pharmaceutical
11.3.1 Takeda Pharmaceutical Company Details
11.3.2 Takeda Pharmaceutical Business Overview
11.3.3 Takeda Pharmaceutical Amino Acid Metabolism Disease Introduction
11.3.4 Takeda Pharmaceutical Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.3.5 Takeda Pharmaceutical Recent Developments
11.4 Astra Zeneca
11.4.1 Astra Zeneca Company Details
11.4.2 Astra Zeneca Business Overview
11.4.3 Astra Zeneca Amino Acid Metabolism Disease Introduction
11.4.4 Astra Zeneca Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.4.5 Astra Zeneca Recent Developments
11.5 Boehringer Ingelheim
11.5.1 Boehringer Ingelheim Company Details
11.5.2 Boehringer Ingelheim Business Overview
11.5.3 Boehringer Ingelheim Amino Acid Metabolism Disease Introduction
11.5.4 Boehringer Ingelheim Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.5.5 Boehringer Ingelheim Recent Developments
11.6 KOWA
11.6.1 KOWA Company Details
11.6.2 KOWA Business Overview
11.6.3 KOWA Amino Acid Metabolism Disease Introduction
11.6.4 KOWA Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.6.5 KOWA Recent Developments
11.7 Kythera
11.7.1 Kythera Company Details
11.7.2 Kythera Business Overview
11.7.3 Kythera Amino Acid Metabolism Disease Introduction
11.7.4 Kythera Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.7.5 Kythera Recent Developments
11.8 Fuji yakuhin
11.8.1 Fuji yakuhin Company Details
11.8.2 Fuji yakuhin Business Overview
11.8.3 Fuji yakuhin Amino Acid Metabolism Disease Introduction
11.8.4 Fuji yakuhin Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.8.5 Fuji yakuhin Recent Developments
11.9 LG Life Science
11.9.1 LG Life Science Company Details
11.9.2 LG Life Science Business Overview
11.9.3 LG Life Science Amino Acid Metabolism Disease Introduction
11.9.4 LG Life Science Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.9.5 LG Life Science Recent Developments
11.10 Metsubishi Tanabe Pharma
11.10.1 Metsubishi Tanabe Pharma Company Details
11.10.2 Metsubishi Tanabe Pharma Business Overview
11.10.3 Metsubishi Tanabe Pharma Amino Acid Metabolism Disease Introduction
11.10.4 Metsubishi Tanabe Pharma Revenue in Amino Acid Metabolism Disease Business (2019-2024)
11.10.5 Metsubishi Tanabe Pharma Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
表と図のリスト
List of Tables Table 1. Global Amino Acid Metabolism Disease Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030 Table 2. Key Players of OTC Table 3. Key Players of Rx Drugs Table 4. Global Amino Acid Metabolism Disease Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030 Table 5. Global Amino Acid Metabolism Disease Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 6. Global Amino Acid Metabolism Disease Market Size by Region (2019-2024) & (US$ Million) Table 7. Global Amino Acid Metabolism Disease Market Share by Region (2019-2024) Table 8. Global Amino Acid Metabolism Disease Forecasted Market Size by Region (2025-2030) & (US$ Million) Table 9. Global Amino Acid Metabolism Disease Market Share by Region (2025-2030) Table 10. Amino Acid Metabolism Disease Market Trends Table 11. Amino Acid Metabolism Disease Market Drivers Table 12. Amino Acid Metabolism Disease Market Challenges Table 13. Amino Acid Metabolism Disease Market Restraints Table 14. Global Amino Acid Metabolism Disease Revenue by Players (2019-2024) & (US$ Million) Table 15. Global Amino Acid Metabolism Disease Revenue Share by Players (2019-2024) Table 16. Global Top Amino Acid Metabolism Disease by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disease as of 2023) Table 17. Global Amino Acid Metabolism Disease Industry Ranking 2022 VS 2023 VS 2024 Table 18. Global 5 Largest Players Market Share by Amino Acid Metabolism Disease Revenue (CR5 and HHI) & (2019-2024) Table 19. Global Key Players of Amino Acid Metabolism Disease, Headquarters and Area Served Table 20. Global Key Players of Amino Acid Metabolism Disease, Product and Application Table 21. Global Key Players of Amino Acid Metabolism Disease, Product and Application Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 24. Global Amino Acid Metabolism Disease Revenue Market Share by Type (2019-2024) Table 25. Global Amino Acid Metabolism Disease Forecasted Market Size by Type (2025-2030) & (US$ Million) Table 26. Global Amino Acid Metabolism Disease Revenue Market Share by Type (2025-2030) Table 27. Global Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 28. Global Amino Acid Metabolism Disease Revenue Share by Application (2019-2024) Table 29. Global Amino Acid Metabolism Disease Forecasted Market Size by Application (2025-2030) & (US$ Million) Table 30. Global Amino Acid Metabolism Disease Revenue Share by Application (2025-2030) Table 31. North America Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 32. North America Amino Acid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million) Table 33. North America Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 34. North America Amino Acid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million) Table 35. North America Amino Acid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 36. North America Amino Acid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million) Table 37. North America Amino Acid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million) Table 38. Europe Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 39. Europe Amino Acid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million) Table 40. Europe Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 41. Europe Amino Acid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million) Table 42. Europe Amino Acid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 43. Europe Amino Acid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million) Table 44. Europe Amino Acid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million) Table 45. China Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 46. China Amino Acid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million) Table 47. China Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 48. China Amino Acid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million) Table 49. Asia Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 50. Asia Amino Acid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million) Table 51. Asia Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 52. Asia Amino Acid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million) Table 53. Asia Amino Acid Metabolism Disease Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030 Table 54. Asia Amino Acid Metabolism Disease Market Size by Region (2019-2024) & (US$ Million) Table 55. Asia Amino Acid Metabolism Disease Market Size by Region (2025-2030) & (US$ Million) Table 56. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Type (2019-2024) & (US$ Million) Table 57. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Type (2025-2030) & (US$ Million) Table 58. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Application (2019-2024) & (US$ Million) Table 59. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Application (2025-2030) & (US$ Million) Table 60. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030 Table 61. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country (2019-2024) & (US$ Million) Table 62. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size by Country (2025-2030) & (US$ Million) Table 63. Merck Company Details Table 64. Merck Business Overview Table 65. Merck Amino Acid Metabolism Disease Product Table 66. Merck Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 67. Merck Recent Developments Table 68. Novartis Company Details Table 69. Novartis Business Overview Table 70. Novartis Amino Acid Metabolism Disease Product Table 71. Novartis Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 72. Novartis Recent Developments Table 73. Takeda Pharmaceutical Company Details Table 74. Takeda Pharmaceutical Business Overview Table 75. Takeda Pharmaceutical Amino Acid Metabolism Disease Product Table 76. Takeda Pharmaceutical Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 77. Takeda Pharmaceutical Recent Developments Table 78. Astra Zeneca Company Details Table 79. Astra Zeneca Business Overview Table 80. Astra Zeneca Amino Acid Metabolism Disease Product Table 81. Astra Zeneca Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 82. Astra Zeneca Recent Developments Table 83. Boehringer Ingelheim Company Details Table 84. Boehringer Ingelheim Business Overview Table 85. Boehringer Ingelheim Amino Acid Metabolism Disease Product Table 86. Boehringer Ingelheim Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 87. Boehringer Ingelheim Recent Developments Table 88. KOWA Company Details Table 89. KOWA Business Overview Table 90. KOWA Amino Acid Metabolism Disease Product Table 91. KOWA Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 92. KOWA Recent Developments Table 93. Kythera Company Details Table 94. Kythera Business Overview Table 95. Kythera Amino Acid Metabolism Disease Product Table 96. Kythera Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 97. Kythera Recent Developments Table 98. Fuji yakuhin Company Details Table 99. Fuji yakuhin Business Overview Table 100. Fuji yakuhin Amino Acid Metabolism Disease Product Table 101. Fuji yakuhin Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 102. Fuji yakuhin Recent Developments Table 103. LG Life Science Company Details Table 104. LG Life Science Business Overview Table 105. LG Life Science Amino Acid Metabolism Disease Product Table 106. LG Life Science Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 107. LG Life Science Recent Developments Table 108. Metsubishi Tanabe Pharma Company Details Table 109. Metsubishi Tanabe Pharma Business Overview Table 110. Metsubishi Tanabe Pharma Amino Acid Metabolism Disease Product Table 111. Metsubishi Tanabe Pharma Revenue in Amino Acid Metabolism Disease Business (2019-2024) & (US$ Million) Table 112. Metsubishi Tanabe Pharma Recent Developments Table 113. Research Programs/Design for This Report Table 114. Key Data Information from Secondary Sources Table 115. Key Data Information from Primary Sources List of Figures Figure 1. Global Amino Acid Metabolism Disease Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million) Figure 2. Global Amino Acid Metabolism Disease Market Share by Type: 2023 VS 2030 Figure 3. OTC Features Figure 4. Rx Drugs Features Figure 5. Global Amino Acid Metabolism Disease Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million) Figure 6. Global Amino Acid Metabolism Disease Market Share by Application: 2023 VS 2030 Figure 7. Hospital Case Studies Figure 8. Retail Pharmacy Case Studies Figure 9. Amino Acid Metabolism Disease Report Years Considered Figure 10. Global Amino Acid Metabolism Disease Market Size (US$ Million), Year-over-Year: 2019-2030 Figure 11. Global Amino Acid Metabolism Disease Market Size, (US$ Million), 2019 VS 2023 VS 2030 Figure 12. Global Amino Acid Metabolism Disease Market Share by Region: 2023 VS 2030 Figure 13. Global Amino Acid Metabolism Disease Market Share by Players in 2023 Figure 14. Global Top Amino Acid Metabolism Disease Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Amino Acid Metabolism Disease as of 2023) Figure 15. The Top 10 and 5 Players Market Share by Amino Acid Metabolism Disease Revenue in 2023 Figure 16. North America Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 17. North America Amino Acid Metabolism Disease Market Share by Type (2019-2030) Figure 18. North America Amino Acid Metabolism Disease Market Share by Application (2019-2030) Figure 19. North America Amino Acid Metabolism Disease Market Share by Country (2019-2030) Figure 20. United States Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 21. Canada Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 22. Europe Amino Acid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million) Figure 23. Europe Amino Acid Metabolism Disease Market Share by Type (2019-2030) Figure 24. Europe Amino Acid Metabolism Disease Market Share by Application (2019-2030) Figure 25. Europe Amino Acid Metabolism Disease Market Share by Country (2019-2030) Figure 26. Germany Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 27. France Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 28. U.K. Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 29. Italy Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 30. Russia Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 31. Nordic Countries Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 32. China Amino Acid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million) Figure 33. China Amino Acid Metabolism Disease Market Share by Type (2019-2030) Figure 34. China Amino Acid Metabolism Disease Market Share by Application (2019-2030) Figure 35. Asia Amino Acid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million) Figure 36. Asia Amino Acid Metabolism Disease Market Share by Type (2019-2030) Figure 37. Asia Amino Acid Metabolism Disease Market Share by Application (2019-2030) Figure 38. Asia Amino Acid Metabolism Disease Market Share by Region (2019-2030) Figure 39. Japan Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 40. South Korea Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 41. China Taiwan Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 42. Southeast Asia Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 43. India Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 44. Australia Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 45. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Size YoY (2019-2030) & (US$ Million) Figure 46. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Share by Type (2019-2030) Figure 47. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Share by Application (2019-2030) Figure 48. Middle East, Africa, and Latin America Amino Acid Metabolism Disease Market Share by Country (2019-2030) Figure 49. Brazil Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 50. Mexico Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 51. Turkey Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 52. Saudi Arabia Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 53. Israel Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 54. GCC Countries Amino Acid Metabolism Disease Market Size YoY Growth (2019-2030) & (US$ Million) Figure 55. Merck Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 56. Novartis Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 57. Takeda Pharmaceutical Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 58. Astra Zeneca Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 59. Boehringer Ingelheim Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 60. KOWA Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 61. Kythera Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 62. Fuji yakuhin Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 63. LG Life Science Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 64. Metsubishi Tanabe Pharma Revenue Growth Rate in Amino Acid Metabolism Disease Business (2019-2024) Figure 65. Bottom-up and Top-down Approaches for This Report Figure 66. Data Triangulation Figure 67. Key Executives Interviewed
01. サンプル提供
ご購入前にサンプル(英語、日本語)が提供可能。
02. カスタマイズサービス
レポートの一部をご購入可能;基本バージョンに加え、ご要望に応じたカスタム委託調査も提供可能。
03. プロフェッショナルな日本語翻訳
AI翻訳ではなく、プロフェッショナルな日本語翻訳をご提供。納期:英語は2-4営業日以内、日本語は8-10営業日以内。
04. 多言語コミュニケーション
日本語、英語、中国語、ヒンディー語、ドイツ語、韓国語、フランス語の7ヶ国語でコミュニケーションサービスをご提供。
05. お支払方法
銀行振込(納品後、ご請求書送付)。
06. アフターサービス
ご購入後、ご質問があれば、3ヵ月以内に無料でアナリストと直接的に連絡できる。
請求書払いの場合:
レポート選択
見積もり依頼
メールでのご注文
入手(英語版は2〜4営業日、日本語版は8〜10営業日)
決済(後払い)
クレジットカード決済の場合:
レポート選択
ウェブサイトでのご注文
決済
入手(英語版は2〜4営業日、日本語版は8〜10営業日)